F. Campigotto

发表

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.

D. Neuberg, O. Onyekwere, J. Keefer, 2013, Blood.

Recurrence of Venous Thromboembolism in Patients With Cancer Treated With Warfarin

D. Neuberg, J. Connors, A. Marshall, 2015, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study.

D. Neuberg, G. Weber, J. Zwicker, 2015, Blood.

Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma

D. Schadendorf, R. Dummer, O. Michielin, 2018, ESMO Open.

De novo acute myeloid leukemia with 20–29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study

D. Neuberg, V. Klepeis, A. Bagg, 2014, American journal of hematology.

The role of 18F‐FDG PET/CT imaging in Waldenstrom macroglobulinemia

I. Ghobrial, X. Leleu, N. Ramaiya, 2011, American journal of hematology.

Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia.

K. Anderson, P. Richardson, S. Rodig, 2013, Blood.

The impact of ASCT on patients with newly diagnosed multiple myeloma who receive RVD induction

N. Munshi, J. Laubach, P. Richardson, 2013 .

Marked hyperferritinemia does not predict for HLH in the adult population.

D. Neuberg, A. Schram, E. Massarotti, 2015, Blood.

Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter study.

D. Neuberg, A. Khorana, J. Zwicker, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical significance of coagulation studies in predicting response to activated recombinant Factor VII in cardiac surgery patients

D. Neuberg, J. Rawn, R. Kaufman, 2012, British Journal of Haematology.

JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib

P. Través, J. D. Di Paolo, B. Murray, 2021, Annals of the Rheumatic Diseases.

Title: Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients

N. Munshi, J. Laubach, P. Richardson, 2013 .

Two-dose emtricitabine/tenofovir alafenamide plus bictegravir prophylaxis protects macaques against SHIV infection

M. Das, T. Cihlar, D. Barouch, 2020, The Journal of antimicrobial chemotherapy.

Results of a Multicenter Pilot Investigation of Bone Marrow Transplantation in Adults with Sickle Cell Disease (STRIDE)

D. Neuberg, Catherine J. Wu, K. Sullivan, 2015 .

Prognostic role of circulating exosomal miRNAs in multiple myeloma.

L. Trippa, P. Moreau, S. Minvielle, 2017, Blood.

Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea.

D. Neuberg, B. Ebert, Erica B Esrick, 2015, Blood.

Abnormalities in IgA and IgM are associated with treatment-resistant ITP.

D. Neuberg, J. Bussel, J. Arnason, 2012, Blood.

Difficult colonoscopies in the propofol era

C. Terranova, B. Martella, N. Minicuci, 2012, BMC Surgery.

BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

D. Scadden, Y. Tai, A. Roccaro, 2013, The Journal of clinical investigation.

Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients

Nikhil C. Munshi, Edie Weller, Kenneth Anderson, 2013, Clinical Cancer Research.

Long Dissociation of Bictegravir from HIV-1 Integrase-DNA Complexes

K. White, B. Brenner, Devleena Shivakumar, 2021, Antimicrobial Agents and Chemotherapy.

Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemia

D. Neuberg, D. DeAngelo, R. Stone, 2015, Modern Pathology.

Trends in all‐cause mortality among patients with chronic myeloid leukemia

D. Neuberg, A. Fathi, Yi-Bin Chen, 2013, Cancer.

A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer

D. Neuberg, Jeffrey C. Allen, M. Kieran, 2013, Pediatric blood & cancer.

Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study

Rebekah K. Loving, D. Neuberg, Catherine J. Wu, 2019, American journal of hematology.

Long-acting capsid inhibitor protects macaques from repeat SHIV challenges

R. Geleziunas, S. Yant, T. Cihlar, 2021, Nature.

Impact of informative censoring on the Kaplan-Meier estimate of progression-free survival in phase II clinical trials.

E. Weller, F. Campigotto, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor‐bearing microparticles: a randomized‐controlled phase II trial (the Microtec study)

D. Neuberg, A. Bullock, H. Lenz, 2013, British journal of haematology.

Biased estimation of thrombosis rates in cancer studies using the method of Kaplan and Meier

D. Neuberg, J. Zwicker, F. Campigotto, 2012, Journal of thrombosis and haemostasis : JTH.

Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access Study

M. Fleseriu, T. L. Mazzuco, Padiporn Limumpornpetch, 2019, Front. Endocrinol..

Accounting for death as a competing risk in cancer-associated thrombosis studies.

D. Neuberg, J. Zwicker, F. Campigotto, 2012, Thrombosis research.

Maximizing the general success of cecal intubation during propofol sedation in a multi-endoscopist academic centre

B. Martella, N. Minicuci, A. Andreotti, 2010, BMC Gastroenterology.

Pasireotide alone or in combination with cabergoline effectively controls urinary free cortisol levels: results from a prospective study in patients with Cushing's disease (CAPACITY)

M. Fleseriu, C. Boguszewski, B. Biller, 2017 .

Reply to T. Olivier et al.

J. Wolchok, F. Hodi, J. Larkin, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.

M. Dyer, S. O’Rahilly, N. Wareham, 2009, The Journal of clinical investigation.

Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)

P. Ascierto, J. Kirkwood, P. Durani, 2023, SKIN The Journal of Cutaneous Medicine.

Association of biomarkers (BMs) with efficacy of adjuvant nivolumab (NIVO) vs placebo (PBO) in patients with resected stage IIB/C melanoma (CA209-76K).

J. Taube, J. Kirkwood, M. Del Vecchio, 2023, Journal of Clinical Oncology.

Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea.

D. Neuberg, B. Ebert, Erica B Esrick, 2015, Blood.

Clinical significance of coagulation studies in predicting response to activated recombinant Factor VII in cardiac surgery patients

D. Neuberg, J. Rawn, R. Kaufman, 2012, British journal of haematology.

Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia.

P. Richardson, S. Rodig, F. Azab, 2013, Blood.